ArticleIntensive care medicine2021
Secondary sclerosing cholangitis: an emerging complication in critically ill COVID-19 patients.
Article in Intensive care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Features of biliary tract diseases in ketamine abusers: a systematic review of case reports.Journal of medical case reports · 2024Pooled it
- Clinical course, prognostic markers, and transplant implications in COVID-19-associated secondary sclerosing cholangitis.Journal of gastroenterology · 2026Article
- Association of esketamine exposure with secondary sclerosing cholangitis in critically ill patients: a retrospective cohort analysis of 20,000 ICU cases.Journal of intensive care · 2026Article
- COVID-19: a multi-organ perspective.Frontiers in cellular and infection microbiology · 2024Review
- Post-COVID-19 cholangiopathy: Systematic review.World journal of methodology · 2023Article
- Relation of COVID-19 with liver diseases and their impact on healthcare systems: The Portuguese case.World journal of gastroenterology · 2023Review
- Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19.BMC anesthesiology · 2023Article
- Secondary Sclerosing Cholangitis After SARS-CoV2: ICU Ketamine Use or Virus-Specific Biliary Tropism and Injury in the Context of Biliary Ischemia in Critically Ill Patients?Hepatic medicine : evidence and research · 2023Article
- COVID-Associated Cast-Forming Cholangiopathy: A Commentary on Disease Mechanism, Treatment, and Prognosis.Hepatic medicine : evidence and research · 2023Article
- COVID-19-Associated Liver Injury.Hepatic medicine : evidence and research · 2023Review
- Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report.World journal of gastrointestinal surgery · 2022Article
- Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review.World journal of gastroenterology · 2022Review
- Secondary sclerosing cholangitis after COVID-19 pneumonia: a report of two cases and review of the literature.Clinical journal of gastroenterology · 2022Review
- COVID-19-induced liver injury in adult patients: A brief overview.World journal of virology · 2022Review
- Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022Article
- Imaging features of COVID-19-associated secondary sclerosing cholangitis on magnetic resonance cholangiopancreatography: a retrospective analysis.Insights into imaging · 2022Article
- Biliary Tract Injury in Patients With COVID-19: A Review of the Current Literature.Gastroenterology & hepatology · 2022Article
- Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome.Critical care (London, England) · 2022Observational
- Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19.Biomedicines · 2021Article
- Ketamine-induced cholangiopathy in ARDS patients.Intensive care medicine · 2021Article
Corrections and comments
- Commented on byMatters of time.2021
- Commented on by
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.